Agreed it is high risk/reward. Given that I probaby would have had to think twice before investing but the main decider for me is the co-operation with the highly respected and well credentialled US Army Walter Reed Medical Centre. For medical research involving brain damage issues its as good as it gets to have them involved. I would imagine WR receives lots of proposals from biotechs and so would be very discriminating in their choice of who to work with based on the program's potential merits. No guarantee of success but it is a big positive to have this particular collaboration.
- Forums
- ASX - By Stock
- Ann: Nyrada Quarterly Activities Report & Appendix 4C
NYR
nyrada inc.
Add to My Watchlist
2.13%
!
24.0¢

Agreed it is high risk/reward. Given that I probaby would have...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $51.67M |
Open | High | Low | Value | Volume |
23.5¢ | 26.5¢ | 23.5¢ | $267.7K | 1.094M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 60000 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 199738 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 60000 | 0.235 |
1 | 20047 | 0.230 |
1 | 50000 | 0.225 |
5 | 88773 | 0.220 |
2 | 120005 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 199738 | 2 |
0.250 | 17500 | 2 |
0.255 | 33711 | 2 |
0.260 | 4500 | 1 |
0.265 | 124139 | 2 |
Last trade - 14.06pm 18/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online